InsiderTrades

Form 4 for PRCT PROCEPT BioRobotics Corp

Accepted 2024-10-31 00:00:00 ET · period of report 2024-10-30 · accession 0001628280-24-044595 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2024-10-31 2024-10-30 PRCT Zadno Reza Pres, CEO, Dir S - Sale+OE $91.00 -288.5K 258.4K -53% -$26.25M
D 2024-10-31 2024-10-30 PRCT Zadno Reza Pres, CEO, Dir M - OptEx $4.37 +288.5K 546.9K +112% +$1.26M
D 2024-10-31 2024-10-30 PRCT Zadno Reza Pres, CEO, Dir M - OptEx $0.00 -288.5K 961.1K -23% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-10-30 S D 288,461 $91.00 258,445 D — —
2 Common Common Stock 2024-10-30 M A 288,461 $4.37 546,906 D — —
3 Derivative Stock Option (Right to Buy) 2024-10-30 M D 288,461 $0.00 961,148 D $4.37 · — to 2030-02-19 288,461 Common Stock (F2) The Stock option was granted on February 20, 2020, and vested over a four year period.